We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Phase I/II Study of 3-Week Cycle Cisplatin–Gemcitabine in Advanced Non-small Cell Lung Cancer.
- Authors
Kusaba, Hitoshi; Tamura, Tomohide; Shimoyama, Tatsu; Hotta, Katsuyuki; Inoue, Akira; Nokihara, Hiroshi; Ueda, Yutaka; Akiyama, Yoshiko; Yamamoto, Noboru; Sekine, Ikuo; Kunitoh, Hideo; Ohe, Yuichiro; Kodama, Tetsuro; Saijo, Nagahiro
- Abstract
Background: The combination of cisplatin and gemcitabine is one of the most active chemotherapy regimens against non-small cell lung cancer. However, the optimum schedule for this combination has not been determined. This study was performed to determine the maximum tolerated dose of gemcitabine combined with cisplatin in a 3-week cycle regimen and to observe safety and efficacy for Japanese patients with advanced non-small cell lung cancer.
- Publication
Japanese Journal of Clinical Oncology, 2002, Vol 32, Issue 2, p43
- ISSN
0368-2811
- Publication type
Article
- DOI
10.1093/jjco/hyf013